Bragg Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.65M | Buy |
13,937
+439
| +3% | +$178K | 0.2% | 132 |
|
|
2025
Q1 | $6.72M | Buy |
13,498
+538
| +4% | +$268K | 0.28% | 117 |
|
|
2024
Q4 | $6.74M | Buy |
12,960
+143
| +1% | +$74.4K | 0.27% | 117 |
|
|
2024
Q3 | $7.93M | Buy |
12,817
+416
| +3% | +$257K | 0.33% | 107 |
|
|
2024
Q2 | $6.86M | Buy |
12,401
+173
| +1% | +$95.7K | 0.31% | 109 |
|
|
2024
Q1 | $7.11M | Buy |
12,228
+380
| +3% | +$221K | 0.32% | 108 |
|
|
2023
Q4 | $6.29M | Sell |
11,848
-1,274
| -10% | -$676K | 0.3% | 112 |
|
|
2023
Q3 | $6.64M | Buy |
13,122
+612
| +5% | +$310K | 0.35% | 103 |
|
|
2023
Q2 | $6.53M | Buy |
12,510
+588
| +5% | +$307K | 0.36% | 105 |
|
|
2023
Q1 | $6.87M | Buy |
11,922
+659
| +6% | +$380K | 0.41% | 100 |
|
|
2022
Q4 | $6.2M | Buy |
11,263
+1,132
| +11% | +$623K | 0.38% | 105 |
|
|
2022
Q3 | $5.14M | Buy |
10,131
+1,013
| +11% | +$514K | 0.35% | 109 |
|
|
2022
Q2 | $4.95M | Buy |
9,118
+1,208
| +15% | +$656K | 0.33% | 108 |
|
|
2022
Q1 | $4.67M | Buy |
7,910
+1,909
| +32% | +$1.13M | 0.27% | 116 |
|
|
2021
Q4 | $3.43M | Hold |
6,001
| – | – | 0.22% | 124 |
|
|
2021
Q3 | $3.43M | Buy |
6,001
+679
| +13% | +$388K | 0.22% | 124 |
|
|
2021
Q2 | $2.69M | Buy |
5,322
+951
| +22% | +$480K | 0.17% | 135 |
|
|
2021
Q1 | $2M | Buy |
4,371
+1,144
| +35% | +$522K | 0.13% | 145 |
|
|
2020
Q4 | $1.5M | Buy |
+3,227
| New | +$1.5M | 0.13% | 144 |
|